The Alliance for Connected Care and other leading organizations called on the Biden Administration to make modifications to the Drug Enforcement Administration's (DEA) proposed rule, Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation, to ensure more flexible prescribing limitations for providers when a controlled [...]
This update includes: Cross-state licensure rules Alliance submits comments to Senate HELP Committee Workforce RFI Sign On Letter Opportunities and notable research and news developments
The Alliance for Connected Care submitted comments in response to the request for information from the Senate HELP Committee on the drivers of the health care workforce shortage. The Alliance specifically outlined the important role that telehealth can play in addressing health care workforce shortages moving forward and why telehealth should be included [...]
Foley & Lardner LLP, an international law firm, released a white paper analysis, which discusses the legal authority and statutory obligation of the Drug Enforcement Administration (DEA) to promulgate regulations specifying the circumstances in which a special registration may be issued, and more.Notably, it concludes:“The recently released proposed rule does not satisfy DEA’s obligation as [...]
This update includes: Sign On Letter Opportunities Release of Congressional Justifications MedPAC Report and notable research and news developments
This update includes: Sign-on letter opportunities Alliance executive director speaks on an Interstate telehealth panel Introduced legislation White House Budget and notable research and news developments
This update includes: Alliance summaries of the DEA NPRM Sen. Warner Statement on DEA NPRM Lawmakers on Both Sides Don't Like DEA's New Telehealth Rules Sign-on opportunity to support the telehealth benefit expansion workers act and notable research and news developments
This update includes: Alliance for Connected Care letter for MAC Meeting DEA NPRM for Telemedicine Prescribing of Controlled Substances HRSA Request to Extend Telehealth Outcome Measures Introduced Telehealth Legislation and notable research and news developments
Telemedicine prescribing of controlled substances when the practitioner and the patient have not had a prior in-person medical evaluation (RIN: 1117-AB40)Drug Enforcement Administration Notice of Proposed RulemakingPublic comments due March 31, 2023DEA Resources: Rule Text Highlights for Medical PractitionersDEA Summary ChartSee companion buprenorphine rule summary hereProposed Rule OverviewThe Ryan Haight Act of 2008 directed the [...]
The Drug Enforcement Administration (DEA) released its Notice of Proposed Rulemaking (NPRM) on buprenorphine via telemedicine encounter, a summary, and highlights for medical practitioners. The proposed rule amends the DEA’s regulations, in concert with the Department of Health and Human Services (HHS), on the circumstances under which individual practitioners are authorized to prescribe schedule [...]